Brought to you by 
INO, Ikaria merge to form new critical care company
27 Feb 2007
Executive Summary
A group of private investors led by New Mountain Capital, Arch Venture Partners, and Venrock Associates has merged critical care medicine developers Ikaria Inc. and INO Therapeutics LLC. Linde Group, the German industrial gas producer that owns INO, gets €380mm ($499mm) in cash plus a 17% equity stake in the new company, bringing the total deal value to $670mm.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
INO, Ikaria merge to form new critical care company
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice